ClinicalTrials.gg
Not yet recruitingNCT07540858GreenmiRNAsUpdated Apr 20, 2026

Microgreens and miRNAs

An interventional study of Microgreens and not received any supplement in Exercise Training, Microgreens and miRNAs, sponsored by Çanakkale Onsekiz Mart University. Not yet recruiting. Open to male participants aged 19 Years to 24 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-20.

Sponsored by Çanakkale Onsekiz Mart University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
19 Years to 24 Years
Sex
Male
01

Study summary

In this study, we investigated the impact of a comprehensive microgreen and wheatgrass juice protocol on the miRNA response following a standardized EIMD model and whether microgreen consumption could modulate key miRNA markers of neuromuscular regeneration and metabolic adaptation, thereby offering a novel nutritional approach to enhancing holistic recovery in athletes.

02

Conditions studied

  • Exercise Training
  • Microgreens
  • miRNAs
03

In context

Lead sponsor

Çanakkale Onsekiz Mart University is the lead sponsor of 51 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 24 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:Recreationally trained athletes were recruited and randomly allocated to either a microgreen supplementation group or a control group. Inclusion criteria were: (i) being an active athlete, (ii) absence of medical to exercise (verified by medical clearance), (iii) voluntary participation, and (iv) full adherence to the study protocol.

-

Exclusion Criteria: Exclusion criteria included: recent musculoskeletal injury (within 6 months), chronic disease or regular medication use, lack of structured training in the previous year, and smoking or alcohol consumption. Participants failing to comply with the protocol, experiencing adverse events, or engaging in high-intensity physical activity during the follow-up period were withdrawn

-

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    Microgreen

    Microgreen received group

    Dietary Supplement: Microgreens

  • Placebo comparator
    control

    not received microgreens

    Other: not received any supplement

Interventions

  • Dietary supplementMicrogreens

    Participants received microgreens for 21 days

  • Othernot received any supplement

    This group will not receive any dietary supplement

06

What researchers measure

Primary outcomes

  1. Muscle recovery related miRNAs

    Real time PCR expressions of serum miRNAs

    Time frame: From enrollment to the end of treatment at 12 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07540858
Lead sponsor
Çanakkale Onsekiz Mart University
Responsible party
Mahmut Açak (PROFESSOR, Çanakkale Onsekiz Mart University) — Principal investigator
First posted
Apr 20, 2026
Start date
May 12, 2026 (estimated)
Primary completion
Jun 12, 2026 (estimated)
Completion
Jul 30, 2026 (estimated)
Last update
Apr 20, 2026

Study contacts

Mahmut Açak, Professor
Contact
mahmut.acak@comu.edu.tr
0 544 445 19 44

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion